High dose hypofractionated proton beam therapy is a safe and feasible treatment for central lung cancer
, , , , , , , , y
16 jun 2017
Acerca de este artículo
Categoría del artículo: Research Article
Publicado en línea: 16 jun 2017
Páginas: 324 - 330
Recibido: 17 ene 2017
Aceptado: 14 may 2017
DOI: https://doi.org/10.1515/raon-2017-0023
Palabras clave
© 2017 Takashi Ono, Tomonori Yabuuchi, Tatsuya Nakamura, Kanako Kimura, Yusuke Azami, Katsumi Hirose, Motohisa Suzuki, Hitoshi Wada, Yasuhiro Kikuchi, Kenji Nemoto
This work is licensed under the Creative Commons Attribution 4.0 International License.
Ono, Takashi
Department of Radiation Oncology, Southern Tohoku Proton Therapy CenterFukushima, Japan
Yabuuchi, Tomonori
Department of Radiation Oncology, Ninohe HospitalIwate, Japan
Nakamura, Tatsuya
Department of Radiation Oncology, Southern Tohoku Proton Therapy CenterFukushima, Japan
Kimura, Kanako
Department of Radiation Oncology, Southern Tohoku Proton Therapy CenterFukushima, Japan
Azami, Yusuke
Department of Radiation Oncology, Southern Tohoku Proton Therapy CenterFukushima, Japan
Hirose, Katsumi
Department of Radiation Oncology, Southern Tohoku Proton Therapy CenterFukushima, Japan
Suzuki, Motohisa
Department of Radiation Oncology, Southern Tohoku Proton Therapy CenterFukushima, Japan
Wada, Hitoshi
Department of Radiation Oncology, Southern Tohoku Proton Therapy CenterFukushima, Japan
Kikuchi, Yasuhiro
Department of Radiation Oncology, Southern Tohoku Proton Therapy CenterFukushima, Japan
Nemoto, Kenji
Department of Radiation Oncology, Yamagata University Faculty of MedicineYamagata, Japan